GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $230,000 | 0.0% | 5,281 | 0.0% | 0.02% | +18.8% |
| Q1 2022 | $230,000 | -1.3% | 5,281 | 0.0% | 0.02% | +6.7% |
| Q4 2021 | $233,000 | +15.3% | 5,281 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $202,000 | -3.8% | 5,281 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $210,000 | -11.4% | 5,281 | -6.2% | 0.02% | -16.7% |
| Q1 2021 | $237,000 | -16.5% | 5,631 | -27.1% | 0.02% | -18.2% |
| Q4 2020 | $284,000 | -20.7% | 7,729 | -18.8% | 0.02% | -31.2% |
| Q3 2020 | $358,000 | -10.3% | 9,517 | -2.7% | 0.03% | -17.9% |
| Q2 2020 | $399,000 | +7.8% | 9,778 | 0.0% | 0.04% | -11.4% |
| Q1 2020 | $370,000 | -22.1% | 9,778 | -3.2% | 0.04% | -2.2% |
| Q4 2019 | $475,000 | +7.0% | 10,105 | -2.9% | 0.04% | -2.2% |
| Q3 2019 | $444,000 | +9.9% | 10,405 | +3.0% | 0.05% | +9.5% |
| Q2 2019 | $404,000 | -4.3% | 10,105 | 0.0% | 0.04% | -8.7% |
| Q1 2019 | $422,000 | +25.6% | 10,105 | +15.1% | 0.05% | +9.5% |
| Q4 2018 | $336,000 | +17.1% | 8,783 | +23.0% | 0.04% | +40.0% |
| Q3 2018 | $287,000 | -0.3% | 7,139 | 0.0% | 0.03% | -9.1% |
| Q2 2018 | $288,000 | +3.2% | 7,139 | 0.0% | 0.03% | +3.1% |
| Q1 2018 | $279,000 | +10.3% | 7,139 | 0.0% | 0.03% | +14.3% |
| Q4 2017 | $253,000 | -15.4% | 7,139 | -2.9% | 0.03% | -17.6% |
| Q3 2017 | $299,000 | -5.7% | 7,354 | 0.0% | 0.03% | -10.5% |
| Q2 2017 | $317,000 | +2.3% | 7,354 | 0.0% | 0.04% | 0.0% |
| Q1 2017 | $310,000 | +1.3% | 7,354 | -7.5% | 0.04% | -5.0% |
| Q4 2016 | $306,000 | -10.8% | 7,949 | 0.0% | 0.04% | -9.1% |
| Q3 2016 | $343,000 | -0.6% | 7,949 | 0.0% | 0.04% | -2.2% |
| Q2 2016 | $345,000 | +7.1% | 7,949 | 0.0% | 0.04% | +7.1% |
| Q1 2016 | $322,000 | -39.1% | 7,949 | -39.4% | 0.04% | -41.7% |
| Q4 2015 | $529,000 | +5.0% | 13,115 | 0.0% | 0.07% | +2.9% |
| Q3 2015 | $504,000 | -7.7% | 13,115 | 0.0% | 0.07% | +1.4% |
| Q2 2015 | $546,000 | -19.0% | 13,115 | -10.2% | 0.07% | -17.9% |
| Q1 2015 | $674,000 | +3.7% | 14,610 | -3.9% | 0.08% | +3.7% |
| Q4 2014 | $650,000 | -10.1% | 15,210 | -3.3% | 0.08% | -12.9% |
| Q3 2014 | $723,000 | -13.5% | 15,730 | +0.6% | 0.09% | -12.3% |
| Q2 2014 | $836,000 | -51.1% | 15,630 | -51.2% | 0.11% | -7.0% |
| Q1 2014 | $1,710,000 | +100.0% | 32,010 | +100.0% | 0.11% | +0.9% |
| Q4 2013 | $855,000 | +6.5% | 16,005 | 0.0% | 0.11% | -0.9% |
| Q3 2013 | $803,000 | +3.6% | 16,005 | +3.2% | 0.11% | -3.4% |
| Q2 2013 | $775,000 | – | 15,505 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |